U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
156661156661ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.CompletedNo Results AvailableGreat Saphenous Vein Disease|Venous RefluxDevice: Segmental RF ablation with the ClosureFAST catheter|Device: Endovenous Laserhttps://ClinicalTrials.gov/show/NCT00509392
156662156662Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent LymphomaCompletedNo Results AvailableLymphoma|Non-Hodgkin LymphomaDrug: Rituximab|Drug: VELCADEhttps://ClinicalTrials.gov/show/NCT00509379
156663156663Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedHas ResultsNon Small Cell Lung CancerDrug: Cisplatin & Gemcitabine|Drug: Cisplatin & Pemetrexed|Drug: Docetaxel & Gemcitabine|Drug: Pemetrexed & Gemcitabinehttps://ClinicalTrials.gov/show/NCT00509366
156664156664N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk NeuroblastomaCompletedNo Results AvailableNeuroblastomaDrug: irinotecan hydrochloride|Drug: vincristine sulfate|Radiation: iobenguane I 131https://ClinicalTrials.gov/show/NCT00509353
156665156665Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral TherapyTerminatedNo Results AvailableDepression|HIV InfectionBehavioral: Cognitive behavioral therapy (CBT)https://ClinicalTrials.gov/show/NCT00509340
156666156666Randomized Clinical Trial of Bisacodyl Versus Placebo on Postoperative Bowel Motility in Elective Colorectal SurgeryCompletedNo Results AvailablePostoperative IleusDrug: bisacodyl|Drug: glucosemonohydricumhttps://ClinicalTrials.gov/show/NCT00509327
156667156667The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional AnalysisRecruitingNo Results AvailableMelanocyte|VitiligoBehavioral: melanocyte self-assembly and functional analysishttps://ClinicalTrials.gov/show/NCT00509314
156668156668Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma MultiformeCompletedNo Results AvailableRecurrent Glioblastoma MultiformeDrug: 131-I-chTNT-1/B MABhttps://ClinicalTrials.gov/show/NCT00509301
156669156669Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered LymphocytesCompletedHas ResultsMelanoma|Skin CancerBiological: autologous anti-MART-1 F5 T-cell receptor|Drug: Cyclophosphamide|Drug: Fludarabine|Biological: Aldesleukin|Biological: autologous anti-MART-1 F5 T-cell receptor gene-engineered tumor infiltrating lymphocyteshttps://ClinicalTrials.gov/show/NCT00509288
156670156670A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)CompletedNo Results AvailableTinea PedisDrug: W0027|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00509275
156671156671Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)CompletedHas ResultsDiabetes Mellitus, Type 2|Renal Insufficiency, ChronicDrug: Sitagliptin|Drug: Glipizide|Drug: Placebo for Sitagliptin|Drug: Placebo for Glipizidehttps://ClinicalTrials.gov/show/NCT00509262
156672156672Aflibercept in Treating Patients With Myelodysplastic SyndromesTerminatedHas ResultsAtypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Secondary Myelodysplastic SyndrBiological: ziv-aflibercept|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00509249
156673156673Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)CompletedHas ResultsDiabetes Mellitus, Type 2|End-Stage Kidney DiseaseDrug: Sitagliptin|Drug: Glipizidehttps://ClinicalTrials.gov/show/NCT00509236
156674156674GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 DiabetesCompletedHas ResultsDiabetes Mellitus Type 2Device: Positive Airway Pressure therapy|Behavioral: Lifestyle counselinghttps://ClinicalTrials.gov/show/NCT00509223
156675156675Study of Telaprevir in Subjects With Hepatic ImpairmentCompletedNo Results AvailableHepatic InsufficiencyDrug: telaprevir (VX-950)https://ClinicalTrials.gov/show/NCT00509210
156676156676Should Non-Eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?RecruitingNo Results AvailableNon-Eosinophilic AsthmaDrug: Placebo|Drug: Fluticasonehttps://ClinicalTrials.gov/show/NCT00509197
156677156677Rituximab and Involved Field Radiotherapy in Early Stage Follicular LymphomaCompletedNo Results AvailableLymphoma, MalignantDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00509184
156678156678Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat EmbolismCompletedNo Results AvailableEmbolism|Femoral FracturesDevice: Reamer Irrigator Aspiratorhttps://ClinicalTrials.gov/show/NCT00509171
156679156679Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria VaccineCompletedNo Results AvailableHealthyBiological: arm I: PfLSA-3-rec with aluminium hydroxide as adjuvant|Biological: arm 2: PfLSA-3-rec with Montanide Isa 720 as adjuvanthttps://ClinicalTrials.gov/show/NCT00509158
156680156680Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNo Results AvailableMultiple SclerosisDrug: Laquinimod|Other: Placebohttps://ClinicalTrials.gov/show/NCT00509145
156681156681A Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy VolunteersCompletedNo Results AvailableObesityDrug: trodusqueminehttps://ClinicalTrials.gov/show/NCT00509132
156682156682ICP Waveform Analysis in Stroke PatientsWithdrawnNo Results AvailableStrokehttps://ClinicalTrials.gov/show/NCT00509119
156683156683Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired PneumoniaCompletedHas ResultsBacterial PneumoniaDrug: Ceftaroline fosamil for Injection|Drug: Ceftriaxone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00509106
156684156684Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received ChemotherapyActive, not recruitingNo Results AvailableLeukemiaDrug: imatinib mesylate|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Other: flow cytometry|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT00509093
156685156685Prognosis in Asymptomatic Mitral Regurgitation (PAMIR) StudyActive, not recruitingNo Results AvailableMitral Regurgitationhttps://ClinicalTrials.gov/show/NCT00509080
156686156686Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With SchizophreniaCompletedHas ResultsSchizophreniaDrug: Galantamine|Drug: CDP-choline|Drug: Placebo|Drug: risperidone, olanzapine, quetiapine, ziprasidone, and/or aripiprazolehttps://ClinicalTrials.gov/show/NCT00509067
156687156687Prevention of Parastomal Hernia With a MeshCompletedNo Results AvailableParastomal HerniaProcedure: Prophylactic meshhttps://ClinicalTrials.gov/show/NCT00509054
156688156688Dasatinib in Treating Patients With Previously Treated Malignant MesotheliomaCompletedHas ResultsMalignant MesotheliomaDrug: dasatinibhttps://ClinicalTrials.gov/show/NCT00509041
156689156689Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial AsthmaCompletedHas ResultsAsthmaDrug: Budesonide|Drug: Conventional Asthma Therapyhttps://ClinicalTrials.gov/show/NCT00509028
156690156690Mass-Drug Administration to Reduce Malaria TransmissionCompletedNo Results AvailableMalaria, FalciparumDrug: Sulphadoxine-pyrimethamine (day 1: 500mg S&25mg P/20 kg)|Drug: Artesunate (day 1,2,3: 4 mg/kg)|Drug: Primaquine-base (day 3: 0.75 mg/kg)|Drug: placebo tabletshttps://ClinicalTrials.gov/show/NCT00509015

* Görseller ve İçerik tekif hakkına sahip olabilir